Hematology parameters of the Yerba Mate and the placebo groups measured at 0 and 12Â weeks. (DOC 56 kb
Data collection points for a polyherbal supplementation intervention for prediabetic adults. (PNG 67...
Table S1. Concomitant medications. Table S2. Average daily dietary intake. (DOCX 14 kb
Figure S1. Flow diagram of the progress stages of the study. Figure S2. Correlation between the redu...
Vital sign parameters of the Yerba Mate and the placebo groups measured at 0, 6 and 12Â weeks. (DOC ...
Dietary assessment parameters of the Yerba Mate and placebo groups measured at 0, 6 and 12Â weeks. (...
CONSORT 2010 checklist of information to include when reporting a randomized trial. (DOC 223 kb
Correlations between change in plasma markers during the study and microbiota composition. (XLSX 16Â...
This is the raw data that was gathered in the clinical trial and was used to establish the data base...
Characteristics of subjects that did not show significant changes during the study. (XLSX 10Â kb
Weight loss in animals with colitis. O-1918 (5Â mg/kg) and/or Abn-CBD (5Â mg/kg) were given twice da...
Participant information sheet and consent form for the study âEffect of a novel probiotic on metab...
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Background: Obesity is a major health problem. A food field research that has recently aroused consi...
The relative risk of persistent bloating in the study group compared to the control group. (DOCX 17Â...
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Data collection points for a polyherbal supplementation intervention for prediabetic adults. (PNG 67...
Table S1. Concomitant medications. Table S2. Average daily dietary intake. (DOCX 14 kb
Figure S1. Flow diagram of the progress stages of the study. Figure S2. Correlation between the redu...
Vital sign parameters of the Yerba Mate and the placebo groups measured at 0, 6 and 12Â weeks. (DOC ...
Dietary assessment parameters of the Yerba Mate and placebo groups measured at 0, 6 and 12Â weeks. (...
CONSORT 2010 checklist of information to include when reporting a randomized trial. (DOC 223 kb
Correlations between change in plasma markers during the study and microbiota composition. (XLSX 16Â...
This is the raw data that was gathered in the clinical trial and was used to establish the data base...
Characteristics of subjects that did not show significant changes during the study. (XLSX 10Â kb
Weight loss in animals with colitis. O-1918 (5Â mg/kg) and/or Abn-CBD (5Â mg/kg) were given twice da...
Participant information sheet and consent form for the study âEffect of a novel probiotic on metab...
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Background: Obesity is a major health problem. A food field research that has recently aroused consi...
The relative risk of persistent bloating in the study group compared to the control group. (DOCX 17Â...
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Data collection points for a polyherbal supplementation intervention for prediabetic adults. (PNG 67...
Table S1. Concomitant medications. Table S2. Average daily dietary intake. (DOCX 14 kb
Figure S1. Flow diagram of the progress stages of the study. Figure S2. Correlation between the redu...
DOI
Add to ORKG